Drive the launch of a pioneering therapy while building vital relationships with healthcare providers and families in the skeletal dysplasia community, ensuring excellence in implementation and compliance for improved patient outcomes.

Lead the charge in overseeing clinical studies, managing medical data, and ensuring compliance with regulatory standards while fostering relationships with key stakeholders and driving trial success.

Accelerate success in KOL management by driving strategic engagement plans, fostering cross-functional collaboration, and leading market insights for a crucial late-stage commercial asset in achondroplasia. Influence and lead initiatives effectively.

Drive clinical study success as a medical lead, overseeing trials, managing regulatory compliance, and fostering investigator relationships while ensuring patient-centric trial strategies.

Grow your career with a vital role in driving the launch of Infigratinib for achondroplasia, partnering with healthcare providers and families. Leverage your expertise to build relationships, strategically target accounts, and meet business goals.